Tumor-derived exosomes (TDEs) carry various bioactive molecules, including TGF-β, caveolin-1, HIF-1α, and β-catenin, which collectively enhance the invasive and migratory capabilities of recipient cells, promote immune evasion, and contribute to drug resistance (Syn et al., 2016). Here, HIF1A is linked to neoplasm.